Towards Healthcare
U.S. Oncology Market to Lead USD 211.78 Billion by 2034

U.S. Oncology Market Evolving with Biomarker and mAbs Growth

Based on market forecasts, the U.S. oncology sector will expand from USD 72.79 billion in 2024 to USD 211.78 billion by 2034, experiencing a CAGR of 11.75%. The West region led the market due to the vital contribution of California in the oncology studies.

Content

  • Last Updated: 28 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The U.S. oncology market holds a valuation of USD 81.34 billion as of 2025, and will expand to USD 211.78 billion by 2034, achieving a CAGR of 11.75% between 2024 and 2034.

West U.S. is currently leading the U.S. oncology market share by 34% due to the emergence of California as a robust hub for studies of oncology.

The U.S. oncology market includes six segments such cancer type, by therapy type, by modality drug class, by end user, by distribution channel, and by region.

Key trends include the rising demand for ADCs, growth in combination therapies, and innovations in drug delivery systems.

US FDA, MoHFW, ACTREC, NCI, CDC, NIH, NCCN, ACS.
Any Questions